reglab/housing_qa huggingface dataset:
MS Code § 73-21-119 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Mississippi Pharmacy Practice Act|§ 73-21-119. Labeling of drug products, biological products, and interchangeable biological products sold at retail

  The label of the container of any drug product which is sold within the State of Mississippi for resale at retail and which requires a prescription to be dispensed at retail shall contain at a minimum the name of the manufacturer of the final dosage unit, expiration date if applicable, batch or lot number and national drug code. The label of the container of any biological product dispensed by a pharmacist shall include its nonproprietary name designated by the federal Food and Drug Administration for use and the name of the manufacturer of the product.   Whenever product selection is made, the pharmacist shall indicate on the label of the dispensed container the initials "G.E." or "I.B.," as appropriate. The label for generic equivalent drugs shall include the proprietary name of the product dispensed or the generic name of the product dispensed and its manufacturer either written in full or appropriately abbreviated, unless the prescriber indicates that the name of the drug product shall not appear on the label. The label for interchangeable biological products shall include its nonproprietary name designated by the federal Food and Drug Administration for use and the name of the manufacturer of the product.
MS Code § 73-21-121 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Mississippi Pharmacy Practice Act|§ 73-21-121. Immunity from civil or criminal liability of dispensing pharmacists and prescribers; immunity from civil liability of persons providing information to board or pharmacist organization; disclosure of information in records of board or pharmacist organization

  Product selection as authorized by Sections 73-21-115 through 73-21-119 shall not constitute evidence of negligence by the dispensing pharmacist when such product selection is in accordance with reasonable and prudent pharmacy practice. No prescriber shall be liable for civil damages or in any criminal prosecution arising from the incorrect product selection by a pharmacist.   Any person having knowledge relating to a pharmacist or to a pharmacy student which might provide grounds for disciplinary action by the board may report relevant facts to the board, and shall by reason of reporting such facts in good faith be immune from civil liability.   Any person furnishing information in the form of data, reports or records to the board or to a pharmacist organization approved by the board to receive such information, where such information is furnished for the purpose of aiding a pharmacist or a pharmacy student impaired by chemical abuse or by mental or by physical illness, shall by reason of furnishing such information in good faith be immune from civil liability.   The records of the board or the records of a pharmacist organization approved by the board to aid pharmacists or pharmacy students impaired by chemical abuse, where such records relate to the impairment, shall be confidential and are not considered open records; provided, however, the board may disclose this confidential information only:   In a disciplinary hearing before the board, or in an appeal of an action or order of the board;   To the pharmacist licensing or disciplinary authorities of other jurisdictions in the case of a pharmacist who is licensed in, or seeking transfer to, another state; or   Pursuant to an order of a court of competent jurisdiction.
MS Code § 73-21-123 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Mississippi Pharmacy Practice Act|§ 73-21-123. Sales of certain drugs not regulated

 Nothing in this chapter shall be construed to prevent, or in any manner interfere with, or to require a permit for the sale of nonnarcotic nonprescription drugs which may be lawfully sold under the United States Food, Drug and Cosmetic Act (21 USCS 301 et seq. as now or hereafter amended) without a prescription, nor shall any rule or regulation be adopted by the board under the provisions of this chapter which shall require the sale of nonprescription drugs by a licensed pharmacist of in a pharmacy or otherwise apply to or interfere with the sale or distribution of such drugs.
MS Code § 73-21-125 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Mississippi Pharmacy Practice Act|§ 73-21-125. Community pharmacies and pharmacists and volunteers working therein immune from civil liability for actions arising out of provision of charitable or gratuitous pharmaceutical products

  Any community pharmacy, including a faith-based community pharmacy, or any licensed pharmacist who voluntarily provides charitable services in a community pharmacy, or any other person who serves as a volunteer in a community pharmacy, shall be immune from liability for any civil action arising out of supplying pharmaceutical products in the course of providing such charitable or gratuitous pharmaceutical products. This section shall not extend immunity to acts of gross negligence or willful or wanton misconduct or to the manufacturer or designer of products provided.   Any community pharmacy seeking immunity under this section shall post a notice, in a conspicuous place adjacent to the area where prescriptions are picked up by consumers, reading substantially as follows: "NOTICE: If you are harmed by medication that you receive here, you do not have the same legal recourse as you have against other pharmacies." Failure to post the notice negates the immunity from liability provided under this section. The notice shall be no less than eleven (11) by fourteen (14) inches in size, and the type used shall be no smaller than thirty-six (36) point and surrounded by a one-inch solid black border.   For purposes of this section, "community pharmacy" means a pharmacy operated solely for charitable purposes, whose only function is to supply gratuitous pharmaceutical products, and which is operated by a nonprofit organization qualified or eligible for qualification as a tax-exempt organization under 26 USCS 501.
MS Code § 73-21-126 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Mississippi Pharmacy Practice Act|§ 73-21-126. Rules and regulations for issuance and renewal of licenses and permits for in and out of state wholesale distributors, chain pharmacy warehouses and re-packagers

  The State Board of Pharmacy shall promulgate rules regarding the issuance and renewal of licenses and permits for new or renewal application requirements for both in- and out-of-state wholesale distributors, chain pharmacy warehouses and repackagers shipping into Mississippi. Requirements for new and/or renewal applications, if information has not been previously provided to the board, will include, but not be limited to, the following:   Type of ownership (individual, partnership or corporation);   Names of principal owners or officers and social security numbers;   Names of designated representatives and social security numbers;   Criminal background checks of applicants and designated representatives as required by rule;   Copy of license in home state;   Bond requirements.     To ensure that all applicants are of good moral character, the board shall conduct a criminal history records check on all applicants for a license.In order to determine the applicant's suitability for licensing, the applicant shall be fingerprinted.The board shall submit the fingerprints to the Department of Public Safety for a check of the state criminal records and forwarded to the Federal Bureau of Investigation for a check of the national criminal records.The Department of Public Safety shall disseminate the results of the state check and the national check to the board for a suitability determination.The board shall be authorized to collect from the applicant the amount of the fee that the Department of Public Safety charges the board for the fingerprinting, whether manual or electronic, and the state and national criminal history records checks.   The board shallpromulgate rules for the establishment of a pedigree or electronicfile to be used by wholesale distributors, chain pharmacy warehousesand repackagers for the purpose of ensuring the integrity of drugsowned, purchased, distributed, returned, transferred and sold whenthe products leave the normal distribution channel.   The board is authorized to use an outside agency to accredit wholesale distributors and repackagers, including the National Association of Boards of Pharmacy's (NABP) Verified Accredited Wholesale Distributors (VAWD) program.   Pharmacies shall not be responsible for verification or adjudication of the pedigree for pharmaceuticals.   The board may exempt wholesalers accredited by the VAWD program from the above requirements.
MS Code § 73-21-129 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Mississippi Pharmacy Practice Act|§ 73-21-129. Certain drug manufacturers required to make provision for return of outdated drugs from pharmacies; investigation and discipline of noncompliant manufacturers; exemption; definitions

  Each manufacturer whose products are distributed within the State of Mississippi shall make adequate provision for the return of outdated drugs from pharmacies, both full and partial containers, excluding biological, infused or intravenously injected drugs and drugs that are inhaled during surgery, within six (6) months after the labeled expiration date, for prompt full credit or refund.   Wholesale distributors and reverse distributors that are required to register with the board and have a permit under Section 73-21-105 shall implement and administer the return policies established by the manufacturer.   If the board receives information that a manufacturer has failed to comply with this section, the board shall investigate the matter and present any evidence of the manufacturer's failure to comply to a review committee composed of the Dean of the University of Mississippi School of Pharmacy, the Executive Director of the State Board of Pharmacy and the Director of the Pharmacy Bureau of the Division of Medicaid, or the designee of any of those officials. The committee shall review the evidence of the manufacturer's failure to comply with this section and make a recommendation to the board regarding the discipline of the manufacturer for its failure to comply. After the board has received the recommendation of the committee, the board may discipline the manufacturer by providing that the manufacturer's products shall be ineligible for use in product selection in any state drug assistance programs.   A pharmacist may not dispense a prescription drug or controlled drug unless the pharmacist has satisfactory evidence that the manufacturer of the drug has a procedure for the return of expired drugs.   Any manufacturer that had a repurchase program in place on January 1, 2008, shall be exempt from the provisions of this section, provided that the repurchase program makes provision for the repurchase of outdated drugs in either full or partial amounts within six (6) months after the labeled expiration date.   As used in this section, the term "biological drug" or "biological product" means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product or analogous product, or arsphenamine or derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment or cure of a disease or condition of human beings.
MS Code § 73-21-151 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Pharmacy Benefit Prompt Pay Act|§ 73-21-151. Short title

 Sections 73-21-151 through 73-21-159 shall be known as the "Pharmacy Benefit Prompt Pay Act."
MS Code § 73-21-157 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Pharmacy Benefit Prompt Pay Act|§ 73-21-157. License required to do business as pharmacy benefit manager; pharmacy benefit managers to file certain financial statements with State Board of Pharmacy; time period for filing statements

  Before beginning to do business as a pharmacy benefit manager, a pharmacy benefit manager shall obtain a license to do business from the board. To obtain a license, the applicant shall submit an application to the board on a form to be prescribed by the board.   Each pharmacy benefit manager providing pharmacy management benefit plans in this state shall file a statement with the board annually by March 1 or within sixty (60) days of the end of its fiscal year if not a calendar year. The statement shall be verified by at least two (2) principal officers and shall cover the preceding calendar year or the immediately preceding fiscal year of the pharmacy benefit manager.   The statement shall be on forms prescribed by the board and shall include:   A financial statement of the organization, including its balance sheet and income statement for the preceding year; and   Any other information relating to the operations of the pharmacy benefit manager required by the board under this section.  However, no pharmacy benefit manager shall be required to disclose proprietary information of any kind to the board.      If the pharmacy benefit manager is audited annually by an independent certified public accountant, a copy of the certified audit report shall be filed annually with the board by June 30 or within thirty (30) days of the report being final.   The board may extend the time prescribed for any pharmacy benefit manager for filing annual statements or other reports or exhibits of any kind for good cause shown. However, the board shall not extend the time for filing annual statements beyond sixty (60) days after the time prescribed by subsection (1) of this section. The board may waive the requirements for filing financial information for the pharmacy benefit manager if an affiliate of the pharmacy benefit manager is already required to file such information under current law with the Commissioner of Insurance and allow the pharmacy benefit manager to file a copy of documents containing such information with the board in lieu of the statement required by this section.   The expense of administering this section shall be assessed annually by the board against all pharmacy benefit managers operating in this state.
MS Code § 73-21-159 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Pharmacy Benefit Prompt Pay Act|§ 73-21-159. Financial examination of pharmacy benefit manager

  In lieu of or in addition to making its own financial examination of a pharmacy benefit manager, the board may accept the report of a financial examination of other persons responsible for the pharmacy benefit manager under the laws of another state certified by the applicable official of such other state.   The board shall coordinate financial examinations of a pharmacy benefit manager that provides pharmacy management benefit plans in this state to ensure an appropriate level of regulatory oversight and to avoid any undue duplication of effort or regulation. The pharmacy benefit manager being examined shall pay the cost of the examination. The cost of the examination shall be deposited in a special fund that shall provide all expenses for the licensing, supervision and examination of all pharmacy benefit managers subject to regulation under Sections 73-21-71 through 73-21-129 and Sections 73-21-151 through 73-21-159.   The board may provide a copy of the financial examination to the person or entity who provides or operates the health insurance plan or to a pharmacist or pharmacy.   The board is authorized to hire independent financial consultants to conduct financial examinations of a pharmacy benefit manager and to expend funds collected under this section to pay the costs of such examinations.
MS Code § 73-21-175 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Pharmacy Audit Integrity Act|§ 73-21-175. Short title

 Sections 73-21-175 through 73-21-189 shall be known as "The Pharmacy Audit Integrity Act."
MS Code § 73-21-177 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Pharmacy Audit Integrity Act|§ 73-21-177. Purpose

 The purpose of Sections 73-21-175 through 73-21-189 is to establish minimum and uniform standards and criteria for the audit of pharmacy records by or on behalf of certain entities.
MS Code § 73-21-179 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Pharmacy Audit Integrity Act|§ 73-21-179. Definitions

 For purposes of Sections 73-21-175 through 73-21-189:   "Entity" means a pharmacy benefit manager, a managed care company, a health plan sponsor, an insurance company, a third-party payor, or any company, group or agent that represents or is engaged by those entities.   "Health insurance plan" means benefits consisting of prescription drugs, other products and supplies, and pharmacist services provided directly, through insurance or reimbursement, or otherwise and including items and services paid for as prescription drugs, other products and supplies, and pharmacist services under any hospital or medical service policy or certificate, hospital or medical service plan contract, preferred provider organization agreement, or health maintenance organization contract offered by a health insurance issuer.   "Individual prescription" means the original prescription for a drug signed by the prescriber, and excludes refills referenced on the prescription.   "Pharmacy benefit manager" means a business that administers the prescription drug/device portion of pharmacy benefit management plans or health insurance plans on behalf of plan sponsors, insurance companies, unions and health maintenance organizations. Pharmacy benefit managers may also provide some, all, but may not be limited to, the following services either directly or through outsourcing or contracts with other entities:   Adjudicate drug claims or any portion of the transaction.   Contract with retail and mail pharmacy networks.   Establish payment levels for pharmacies.   Develop formulary or drug list of covered therapies.   Provide benefit design consultation.   Manage cost and utilization trends.   Contract for manufacturer rebates.   Provide fee-based clinical services to improve member care.   Third-party administration.   "Pharmacy benefit management plan" means an arrangement for the delivery of pharmacist's services in which a pharmacy benefit manager undertakes to administer the payment or reimbursement of any of the costs of pharmacist's services for an enrollee on a prepaid or insured basis that (i) contains one or more incentive arrangements intended to influence the cost or level of pharmacist's services between the plan sponsor and one or more pharmacies with respect to the delivery of pharmacist's services; and (ii) requires or creates benefit payment differential incentives for enrollees to use under contract with the pharmacy benefit manager.   "Pharmacist," "pharmacist services" and "pharmacy" or "pharmacies" shall have the same definitions as provided in Section 73-21-73.
MS Code § 73-21-181 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Pharmacy Audit Integrity Act|§ 73-21-181. Application

 Sections 73-21-175 through 73-21-189 shall apply to any audit of the records of a pharmacy conducted by a managed care company, nonprofit hospital or medical service organization, insurance company, third-party payor, pharmacy benefit manager, a health program administered by a department of the state or any entity that represents those companies, groups, or department.
MS Code § 73-21-185 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Pharmacy Audit Integrity Act|§ 73-21-185. Appeals; dismissal of audit report; mediation of unresolved issues

  Each entity conducting an audit shall establish a written appeals process under which a pharmacy may appeal an unfavorable preliminary audit report to the entity.   If, following the appeal, the entity finds that an unfavorable audit report or any portion thereof is unsubstantiated, the entity shall dismiss the audit report or that portion without the necessity of any further action.   If, following the appeal, any of the issues raised in the appeal are not resolved to the satisfaction of either party, that party may ask for mediation of those unresolved issues. A certified mediator shall be chosen by agreement of the parties from the Court Annexed Mediators List maintained by the Mississippi Supreme Court.
MS Code § 73-21-187 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Pharmacy Audit Integrity Act|§ 73-21-187. Use of extrapolation in calculating recoupments or penalties prohibited

 Notwithstanding any other provision in Sections 73-21-175 through 73-21-189, the entity conducting the audit shall not use the accounting practice of extrapolation in calculating recoupments or penalties for audits. An extrapolation audit means an audit of a sample of prescription drug benefit claims submitted by a pharmacy to the entity conducting the audit that is then used to estimate audit results for a larger batch or group of claims not reviewed by the auditor.
MS Code § 73-21-189 (2020)
2020 Mississippi Code|Title 73 - Professions and Vocations|Chapter 21 - Pharmacists|Pharmacy Audit Integrity Act|§ 73-21-189. Limitation of applicability of Sections 73-21-175 through 73-21-189

 Sections 73-21-175 through 73-21-189 do not apply to any audit, review or investigation that involves alleged fraud, willful misrepresentation or abuse.